# Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness

> **NCT03038919** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 30 (estimated)

## Conditions studied

- Critical Illness Polyneuropathies

## Interventions

- **DRUG:** Testosterone cypionate
- **OTHER:** Standard nutrition and physical therapy at ICU

## Key facts

- **NCT ID:** NCT03038919
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-10
- **Final completion:** 2018-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038919, "Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03038919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*